Thursday, January 11, 2024 |
||
Session I: Liver Metastasis (Multidisciplinary) |
Moderators: Martijn Meijerwink, MD, PhD & Luigi Solbiati, MD | Faculty: |
7:00 AM – 6:45 PM | Registration open | Visit exhibit hall | |
7:55 AM – 8:00 AM | Welcome & Introductions Chair: Govindarajan Narayanan, MD |
|
8:00 AM | Surgical strategies in mCRC | Domenech Asbun, MD (Surgical Oncology) |
8:10 AM | Getting the mCRC patient to surgery – Role of PVE & HVD | Ripal Gandhi, MD (IO) |
8:20 AM | Chemotherapeutic advances in mCRC | Antonio Ucar, MD (Medical Oncology) |
8:30 AM | The ACCLAIM trial | Costantinos Sofocleous, MD, PhD (IO) |
8:40 AM | Lessons learnt from the AMCORE registry | Robbert Puijk, MD, PhD (IO) |
8:50 AM | Pushing the boundaries with stereotactic Ablation | Reto Bale, MD (IO) |
9:00 AM | Minimally Invasive to Noninvasive- HOPE 4 LIVER Results | Govindarajan Narayanan, MD (IO) |
9:10 AM | Prospective trial of DEBIRI with 30-60 micron microspheres | Katerina Malagari, MD (IO) |
9:20 AM | Y-90 Dosimetry concepts | David Liu, MD (IO) |
9:30 AM | Incorporating Y-90 into the mCRC treatment algorithm | Ripal Gandhi, MD (IO) |
9:40 AM | Eye 90- The next frontier in SIRT? | Nadine Abi-Jaoudeh, MD (IO) |
9:50 AM | Choosing between locoregional treatment options for metastatic NE tumors | Ricardo Garcia-Monaco, MD, PhD (IO) |
10:00 AM | Q&A | |
10:10 – 10:30 AM | Refreshment Break and Visit Exhibits | |
Session II: Liver Metastasis Tumor Board |
Moderators: David Liu, MD & Constantinos Sofocleous, MD, PhD | Faculty: |
10:30-11:30 AM | Liver Metastasis Tumor Board | Liver Metastasis Faculty |
Session III: Vascular Medicine in Oncology |
Moderators: Constantino Pena, MD & Yolanda Bryce, MD | Faculty: |
11:30 AM | Acute Limb Ischemia in the cancer population | Olekandra Kutsenko, MD (IO) |
11:40 AM | DVT management in the oncologic population | Varshana Gurusamy, MD (IO) |
11:50 AM | Thrombectomy in Cancer patients | Osman Ahmed, MD (IO) |
12:00 – 1:10 PM | Lunch & Learn Non-CE Session: Ablation for Primary and Metastatic Liver (CRLM and HCC) Moderators: Yilun Koethe, MD & Ripal Gandhi, MD |
|
1. Three-Dimensional Rotational Angiography (3DRA) Assisted Cone Beam Computed Tomography (CBCT) Guided Microwave Ablation (MWA) in the Treatment of Hepatic Malignancy
2. Validation of a Mathematic 3D-liver Model to Predict the Most Suitable Local Treatment Option for Colorectal Liver Metastases (CRLM): Recommendations from the COLLISION Expert Panel
3. Predictors of the Size of the Microwave Ablation Zone after In Patients with Primary and Secondary Liver Tumors; A Retrospective Analysis
4. Reduction of Respiratory Motion Effect on Histotripsy Treatment Zones Using High Frequency Jet Ventilation
5. The Added Diagnostic Value of Transcatheter CT-Hepatic Arteriography for Intraprocedural Detection of Previously Unknown Colorectal Liver Metastases During Percutaneous Ablation and Impact on the Definitive Treatment Plan
6. Efficacy of Thermal Ablation for Small-Size (0–3 cm) Versus Intermediate-Size (3–5 cm) Colorectal Liver Metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE)
7. Histotripsy of the Kidney: How Resistant are the Ureter and Renal Pelvis to Damage when Directly Targeted?
Q&A |
||
1:10 – 1:30 PM | Dessert & Refreshments. Visit Exhibit Hall | |
Session IV: Breast Cancer & Gyn Oncology |
Moderators: Reshma Mahtani, DO & Wael Saad, MD | Faculty: |
1:30 PM | Surgical management in breast cancer | Starr Mautner, MD (Surgical Oncology) |
1:40 PM | Advances in the systemic management of breast cancer | Reshma Mahtani, DO (Medical Oncology) |
1:50 PM | Role of Radiation in breast cancer | Joe Panoff, MD (Radiation Oncology) |
2:00 PM | Ablation in Benign & Malignant Breast Disease (pre-recorded) | Yolanda Bryce, MD (IO) |
2:10 PM | Transcatheter treatment in breast cancer | Wael Saad, MD (IO) |
2:20 PM | Q&A | |
Session V: Lung Cancer |
Moderators: Brian Lally, MD & Constantinos Sofocleous, MD, PhD | Faculty: |
2:30 PM | Advances in chemotherapy in Lung cancer | Luis Raez, MD (Medical Oncology) |
2:40 PM | Optimizing radiation in primary lung malignancies | Brian Lally, MD (Radiation Oncology) |
2:50 PM | Approach to lung cancer in the UK | Steve Bandula, MD, PhD (IO) |
3:00 PM | PEF in Lung Cancer | Robert Suh, MD (IO) |
3:10 PM | Robotic assisted Lung ablations | Nicos Fotiadis, MD, PhD |
3:20 PM | Case discussion / Q&A Case Presentation by Brian Lally, MD |
Lung Cancer Faculty |
3:40-4:00 PM | Refreshment Break and Visit Exhibits | |
Session VI: Sarcoma/Pain Management (Multidisciplinary) |
Moderators: Jack Jennings, MD, PhD & Giovanni Paraliticci, MD | Faculty: |
4:00 PM | Chemotherapeutic management of sarcoma | Breelyn Wilky, MD (Medical Oncology) |
4:10 PM | Overview of Management of Epithelioid Hemangioendothelioma | Varshana Gurusamy, MD (IO) |
4:20 PM | Focal Ablation in Sarcomas | Steve Bandula, MD, PhD (IO) |
4:30 PM | IRE and Desmoid tumors, early experience | Chris Sinsabaugh, MD (IO) |
4:40 PM | Pain Management – Rising role of interventional oncology | Dimitrios Fillipiadis, MD, PhD (IO) |
4:50 PM | Blocks in Pain Management – How I Do It | Blake Jacks, MD (IO) |
5:00 PM | Q&A | |
Session VII: Bone/Spine |
Moderators: Afshin Gangi, MD & Alda Tam, MD | Faculty: |
5:10 PM | Surgical Management of Bone Malignancies | Giovanni Paraliticci, MD (Surgical Oncology) |
5:20 PM | Radiation Oncology in MSK Tumors | Rupesh Kotecha, MD (Radiation Oncology) |
5:30 PM | MR guided Bone Interventions | Alda Tam, MD (IO) |
5:40 PM | Role of Cement in Bone Stabilization | Gina Landinez, MD (IO) |
5:50 PM | Emerging Indications and Techniques in MSK Ablation | Alan Alper Sag, MD (IO) |
6:00 PM | Percutaneous Treatment of Bone Tumors – Case review | Afshin Gangi, MD (IO) |
6:10 PM | Percutaneous Thermal Ablation of Vertebral Metastasis | Jack Jennings, MD, PhD (IO) |
6:20 PM | Q&A | |
6:40 PM | SOCIAL EVENT: Welcome & Wine Tasting Exhibit Hall – Open to all attendees |